Bone and renal safety profile at 72 weeks after switching to tenofovir alafenamide in chronic hepatitis B patients

CHB patients who switch from long-term TDF to TAF therapy show sustained improvement in proximal tubular function and hip BMD. Weight gain was noted, and long-term studies are needed to evaluate its effect on patient outcomes.